Handan Institute of liver diseases was established on September 12, 2006, with the approval of Handan science and Technology Commission and the Municipal Bureau of civil affairs of Hebei Province. Liu Molin, the academic leader, served as the director. Handan Institute of liver disease is a comprehensive institute integrating medical research, clinical treatment, traditional Chinese medicine preparation and new diagnostic technology research and development. It focuses on liver disease research, maintains academic exchanges, new technology research and promotion with liver disease diagnosis and treatment institutions at home and abroad for a long time, and grasps the scientific and technological trends at home and abroad.

The traditional Chinese medicine dredging chemical fiber method originally developed by the Institute has been unanimously recognized by liver disease experts at home and abroad. According to the dredging chemical fiber method of traditional Chinese medicine, 12 provincial batches of dredging chemical fiber series Chinese patent medicines have been developed, and the national quasi brand traditional Chinese medicine with independent intellectual property rights has obtained a number of traditional Chinese medicine invention patents, such as Anluo chemical fiber pill, dredging chemical fiber pill, mieyidan and other traditional Chinese medicine invention patents. "Anluohuaxian pill", one of the series drugs developed by Handan liver disease hospital, a subordinate institution of Handan Institute of liver diseases, has been developed as the national drug approval. It is the only national new drug approved by SFDA for the treatment of mid-term liver cirrhosis. It is listed as the "confidential product" of traditional Chinese medicine prescription of the Ministry of health, and has been included in four major scientific and technological projects of the 12th Five Year Plan and the 13th five year plan, It has been included in the guidelines for the prevention and treatment of chronic hepatitis B, the guidelines for the diagnosis and treatment of liver cirrhosis, the guidelines for the diagnosis and treatment of ascites and related complications of liver cirrhosis, the guidelines for the prevention and treatment of esophageal variceal bleeding in cirrhotic portal hypertension test, the guidelines for the clinical application of Chinese patent medicine, the expert consensus on liver inflammation and its prevention and treatment, and the routine diagnosis and treatment of infectious diseases by the Chinese Medical Association, It was used in the clinical study of treating pulmonary fibrosis after "Xinguan".

The Institute has nearly 2000 square meters of traditional Chinese medicine preparation room according to the national GPP standard, equipped with a variety of advanced supporting pharmaceutical equipment, and improved the process of traditional Chinese medicine preparation. The affiliated institution Handan liver disease hospital has introduced medical equipment such as automatic biochemical analyzer, PCR quantitative detector, automatic time-resolved fluorescence immunoanalyzer, German Siemens color Doppler ultrasound, noninvasive diagnosis of liver fibrosis, and introduced new treatment technologies such as "promoting hepatocyte regeneration and soft liver".

Handan liver disease research institute takes "overcoming the problem of liver disease" as its mission, deeply excavates the essence of traditional Chinese medicine, gives full play to the advantages of traditional Chinese medicine, combines clinical practice experience, constantly innovates, forge ahead, and strives for the goal of "no liver disease in the world" for life!